How to Assess Breathlessness in Chronic Obstructive Pulmonary Disease

References

• Parshall MB, Schwartzstein RM, Adams L, et al. An Official American Thoracic Society Statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012;185(4):435–452. doi:10.1164/rccm.201111-2042ST
   PubMed Web of Science ®Google Scholar
• Bowden JA, To TH, Abernethy AP, Currow DC. Predictors of chronic breathlessness: a large population study. BMC Public Health. 2011;11:33. doi:10.1186/1471-2458-11-33
   PubMed Web of Science ®Google Scholar
• Currow DC, Plummer JL, Crockett A, Abernethy AP. A community population survey of prevalence and severity of dyspnea in adults. J Pain Symptom Manage. 2009;38(4):533–545. doi:10.1016/j.jpainsymman.2009.01.006
   PubMed Web of Science ®Google Scholar
• Sandberg J, Ekström M, Börjesson M, et al. Underlying contributing conditions to breathlessness among middle-aged individuals in the general population: a cross-sectional study. BMJ Open Respir Res. 2020;7(1):e000643. doi:10.1136/bmjresp-2020-000643
   PubMed Web of Science ®Google Scholar
• Jensen D, Ofir D, O’Donnell DE. Effects of pregnancy, obesity and aging on the intensity of perceived breathlessness during exercise in healthy humans. Respir Physiol Neurobiol. 2009;167(1):87–100. doi:10.1016/j.resp.2009.01.011
   PubMed Web of Science ®Google Scholar
• Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage. 2006;31(1):58–69. doi:10.1016/j.jpainsymman.2005.06.007
   PubMed Web of Science ®Google Scholar
• Johnson MJ, Bowden JA, Abernethy AP, Currow DC. To what causes do people attribute their chronic breathlessness? A population survey. J Palliat Med. 2012;15(7):744–750. doi:10.1089/jpm.2011.0430
   PubMed Web of Science ®Google Scholar
• Hutchinson A, Pickering A, Williams P, Bland JM, Johnson MJ. Breathlessness and presentation to the emergency department: a survey and clinical record review. BMC Pulm Med. 2017;17(1):53. doi:10.1186/s12890-017-0396-4
   PubMedGoogle Scholar
• Carette H, Zysman M, Morelot-Panzini C, et al. Prevalence and management of chronic breathlessness in COPD in a tertiary care center. BMC Pulm Med. 2019;19(1):95. doi:10.1186/s12890-019-0851-5
   PubMedGoogle Scholar
• Mullerova H, Lu C, Li H, Tabberer M. Prevalence and burden of breathlessness in patients with chronic obstructive pulmonary disease managed in primary care. PLoS One. 2014;9(1):e85540. doi:10.1371/journal.pone.0085540
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Ribera A. Understanding the impact of symptoms on the burden of COPD. Respir Res. 2017;18(1):67. doi:10.1186/s12931-017-0548-3
   PubMed Web of Science ®Google Scholar
• Lewthwaite H, Effing TW, Lenferink A, Olds T, Williams MT. Improving physical activity, sedentary behaviour and sleep in COPD: perspectives of people with COPD and experts via a Delphi approach. PeerJ. 2018;6:e4604. doi:10.7717/peerj.4604
   PubMed Web of Science ®Google Scholar
• Michalovic E, Jensen D, Dandurand RJ, et al. Description of participation in daily and social activities for individuals with COPD. COPD. 2020;17(5):1–14. doi:10.1080/15412555.2020.1798373
   PubMedGoogle Scholar
• Currow DC, Dal Grande E, Ferreira D, Johnson MJ, McCaffrey N, Ekström M. Chronic breathlessness associated with poorer physical and mental health-related quality of life (SF-12) across all adult age groups. Thorax. 2017;72(12):1151–1153. doi:10.1136/thoraxjnl-2016-209908
   PubMed Web of Science ®Google Scholar
• Smith AK, Currow DC, Abernethy AP, et al. Prevalence and outcomes of breathlessness in older adults: a National Population Study. J Am Geriatr Soc. 2016;64(10):2035–2041. doi:10.1111/jgs.14313
   PubMed Web of Science ®Google Scholar
• Sandberg J, Engstrom G, Ekstrom M. Breathlessness and incidence of COPD, cardiac events and all-cause mortality: a 44-year follow-up from middle age throughout life. PLoS One. 2019;14(3):e0214083. doi:10.1371/journal.pone.0214083
   PubMed Web of Science ®Google Scholar
• Frostad A, Soyseth V, Haldorsen T, Andersen A, Gulsvik A. Respiratory symptoms and 30 year mortality from obstructive lung disease and pneumonia. Thorax. 2006;61(11):951–956. doi:10.1136/thx.2006.059436
   PubMed Web of Science ®Google Scholar
• Sundh J, Ekstrom M. Persistent disabling breathlessness in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2016;11:2805–2812. doi:10.2147/COPD.S119992
   PubMed Web of Science ®Google Scholar
• Johnson MJ, Yorke J, Hansen-Flaschen J, et al. Towards an expert consensus to delineate a clinical syndrome of chronic breathlessness. Eur Respir J. 2017;49(5):1602277. doi:10.1183/13993003.02277-2016
   PubMed Web of Science ®Google Scholar
• Hutchinson A, Johnson MJ, Currow D. Acute-on-chronic breathlessness: recognition and response. J Pain Symptom Manage. 2019;57(5):e4–e5. doi:10.1016/j.jpainsymman.2019.01.012
   PubMed Web of Science ®Google Scholar
• Hutchinson A, Galvin K, Johnson MJ. “So, I try not to go … ” acute-on-chronic breathlessness and presentation to the emergency department: in-depth interviews with patients, carers, and clinicians. J Pain Symptom Manage. 2020;60(2):316–325. doi:10.1016/j.jpainsymman.2020.03.014
   PubMed Web of Science ®Google Scholar
• Jolley CJ, Luo YM, Steier J, Rafferty GF, Polkey MI, Moxham J. Neural respiratory drive and breathlessness in COPD. Eur Respir J. 2015;45(2):355–364. doi:10.1183/09031936.00063014
   PubMed Web of Science ®Google Scholar
• Jolley CJ, Moxham J. A physiological model of patient-reported breathlessness during daily activities in COPD. Eur Respir J. 2009;18(112):66–79. doi:10.1183/09059180.00000809
   Google Scholar
• O’Donnell DE, Milne KM, James MD, de Torres JP, Neder JA. Dyspnea in COPD: new mechanistic insights and management implications. Adv Ther. 2020;37(1):41–60. doi:10.1007/s12325-019-01128-9
   PubMed Web of Science ®Google Scholar
• Faull OK, Marlow L, Finnegan SL, Pattinson KTS. Chronic breathlessness: re-thinking the symptom. Eur Respir J. 2018;51(1):1702238. doi:10.1183/13993003.02238-2017
   PubMedGoogle Scholar
• Marlow LL, Faull OK, Finnegan SL, Pattinson KTS. Breathlessness and the brain: the role of expectation. Curr Opin Support Palliat Care. 2019;13(3):200–210. doi:10.1097/SPC.0000000000000441
   PubMed Web of Science ®Google Scholar
• Bailey PH. The dyspnea-anxiety-dyspnea cycle–COPD patients’ stories of breathlessness: “It’s scary/when you can’t breathe”. Qual Health Res. 2004;14(6):760–778. doi:10.1177/1049732304265973
   PubMed Web of Science ®Google Scholar
• Eltayara L, Becklake MR, Volta CA, Milic-Emili J. Relationship between chronic dyspnea and expiratory flow limitation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996;154(6):1726–1734. doi:10.1164/ajrccm.154.6.8970362
   PubMed Web of Science ®Google Scholar
• Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest. 1984;85(6):751–758. doi:10.1378/chest.85.6.751
   PubMed Web of Science ®Google Scholar
• Santos LM, Pedro PI, Dias A, Forte CB, Raposo P, Rodrigues MF. Relationship between dyspnea/oxygen saturation and leg discomfort/6-minute walking distance in patients with COPD participating in pulmonary rehabilitation. Pulmonology. 2019;25(6):357–360. doi:10.1016/j.pulmoe.2019.07.012
   PubMed Web of Science ®Google Scholar
• Banzett RB, Pedersen SH, Schwartzstein RM, Lansing RW. The affective dimension of laboratory dyspnea: air hunger is more unpleasant than work/effort. Am J Respir Crit Care Med. 2008;177(12):1384–1390. doi:10.1164/rccm.200711-1675OC
   PubMed Web of Science ®Google Scholar
• Herigstad M, Faull OK, Hayen A, et al. Treating breathlessness via the brain: changes in brain activity over a course of pulmonary rehabilitation. Eur Respir J. 2017;50(3):1701029. doi:10.1183/13993003.01029-2017
   PubMed Web of Science ®Google Scholar
• Ahmadi Z, Sandberg J, Shannon-Honson A, Vandersman Z, Currow DC, Ekström M. Is chronic breathlessness less recognised and treated compared with chronic pain? A case-based randomised controlled trial. Eur Respir J. 2018;52(3):1800887. doi:10.1183/13993003.00887-2018
   PubMed Web of Science ®Google Scholar
• Gysels M, Higginson IJ. Access to services for patients with chronic obstructive pulmonary disease: the invisibility of breathlessness. J Pain Symptom Manage. 2008;36(5):451–460. doi:10.1016/j.jpainsymman.2007.11.008
   PubMed Web of Science ®Google Scholar
• Lunn S, Dharmagunawardena R, Lander M, Sweeney J. It’s hard to talk about breathlessness: a unique insight from respiratory trainees. Clin Med. 2019;19(4):344–347. doi:10.7861/clinmedicine.19-4-344
   PubMed Web of Science ®Google Scholar
• Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10(4):407–415. doi:10.1016/0197-2456(89)90005-6
   PubMedGoogle Scholar
• Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR; Clinical Significance Consensus Meeting G. Methods to explain the clinical significance of health status measures. Mayo Clin Proc. 2002;77(4):371–383. doi:10.4065/77.4.371
   PubMed Web of Science ®Google Scholar
• Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41(5):582–592. doi:10.1097/01.MLR.0000062554.74615.4C
   PubMed Web of Science ®Google Scholar
• Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93(3):580–586. doi:10.1378/chest.93.3.580
   PubMed Web of Science ®Google Scholar
• Brookes SM. Task group on surveillance for respiratory hazards in the occupational setting. ATS News. 1982;8:12–16.
   Google Scholar
• Fletcher C. Standardised questionnaire on respiratory symptoms: a statement prepared and approved by the MRC Committee on the Aetiology of Chronic Bronchitis (MRC breathlessness score). BMJ. 1960;2(2):1665.
   PubMedGoogle Scholar
• Sandberg J, Johnson MJ, Currow DC, Ekstrom M. Validation of the dyspnea exertion scale of breathlessness in people with life-limiting illness. J Pain Symptom Manage. 2018;56(3):430–435. doi:10.1016/j.jpainsymman.2018.05.002
   PubMed Web of Science ®Google Scholar
• McGavin CR, Artvinli M, Naoe H, McHardy GJ. Dyspnoea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease. Br Med J. 1978;2(6132):241–243. doi:10.1136/bmj.2.6132.241
   PubMedGoogle Scholar
• Aguilaniu B, Gonzalez-Bermejo J, Regnault A, et al. Disability related to COPD tool (DIRECT): towards an assessment of COPD-related disability in routine practice. Int J Chron Obstruct Pulmon Dis. 2011;6:387–398. doi:10.2147/COPD.S20007
   PubMed Web of Science ®Google Scholar
• Eakin EG, Sassi-Dambron DE, Ries AL, Kaplan RM. Reliability and validity of dyspnea measures in patients with obstructive lung disease. Int J Behav Med. 1995;2(2):118–134. doi:10.1207/s15327558ijbm0202_3
   PubMed Web of Science ®Google Scholar
• Chhabra SK, Gupta AK, Khuma MZ. Evaluation of three scales of dyspnea in chronic obstructive pulmonary disease. Ann Thorac Med. 2009;4(3):128–132. doi:10.4103/1817-1737.53351
   PubMed Web of Science ®Google Scholar
• Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–586. doi:10.1136/thx.54.7.581
   PubMed Web of Science ®Google Scholar
• Mahler DA, Ward J, Waterman LA, McCusker C, Zuwallack R, Baird JC. Patient-reported dyspnea in COPD reliability and association with stage of disease. Chest. 2009;136(6):1473–1479. doi:10.1378/chest.09-0934
   PubMed Web of Science ®Google Scholar
• Bausewein C, Farquhar M, Booth S, Gysels M, Higginson IJ. Measurement of breathlessness in advanced disease: a systematic review. Respir Med. 2007;101(3):399–410. doi:10.1016/j.rmed.2006.07.003
   PubMed Web of Science ®Google Scholar
• Dela Coleta K, Silveira LVA, Lima DF, Rampinelli EA, Godoy I, Godoy I. Predictors of first-year survival in patients with advanced COPD treated using long-term oxygen therapy. Respir Med. 2008;102(4):512–518. doi:10.1016/j.rmed.2007.12.003
   PubMed Web of Science ®Google Scholar
• Oga T, Nishimura K, Tsukino M, Hajiro T, Mishima M. Dyspnoea with activities of daily living versus peak dyspnoea during exercise in male patients with COPD. Respir Med. 2006;100(6):965–971. doi:10.1016/j.rmed.2005.10.006
   PubMed Web of Science ®Google Scholar
• Sundh J, Janson C, Lisspers K, Stallberg B, Montgomery S. The Dyspnoea, Obstruction, Smoking, Exacerbation (DOSE) index is predictive of mortality in COPD. Prim Care Respir J. 2012;21(3):295–301. doi:10.4104/pcrj.2012.00054
   PubMedGoogle Scholar
• Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002;121(5):1434–1440. doi:10.1378/chest.121.5.1434
   PubMed Web of Science ®Google Scholar
• Casanova C, Marin JM, Martinez-Gonzalez C, et al. Differential Effect of Modified Medical Research Council Dyspnea, COPD assessment test, and clinical COPD questionnaire for symptoms evaluation within the new GOLD staging and mortality in COPD. Chest. 2015;148(1):159–168. doi:10.1378/chest.14-2449
   PubMed Web of Science ®Google Scholar
• From the global strategy for the diagnosis, management and prevention of COPD, global initiative for chronic obstructive lung disease (GOLD); 2021. Available from: http://goldcopd.org. Accessed May 13, 2021.
   Google Scholar
• Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;158(4):1185–1189. doi:10.1164/ajrccm.158.4.9802091
   PubMed Web of Science ®Google Scholar
• Mahler DA, Ward J, Waterman LA, Baird JC. Longitudinal changes in patient-reported dyspnea in patients with COPD. COPD. 2012;9(5):522–527. doi:10.3109/15412555.2012.701678
   PubMedGoogle Scholar
• Guyatt G. Measuring health status in chronic airflow limitation. Eur Respir J. 1988;1(6):560–564.
   PubMed Web of Science ®Google Scholar
• Witek TJ Jr, Mahler DA. Meaningful effect size and patterns of response of the transition dyspnea index. J Clin Epidemiol. 2003;56(3):248–255. doi:10.1016/S0895-4356(02)00589-9
   PubMed Web of Science ®Google Scholar
• Mahler DA, Witek TJ Jr. The MCID of the transition dyspnea index is a total score of one unit. Chronic Obstr Pulm Dis. 2005;2(1):99–103. doi:10.1081/COPD-200050666
   Google Scholar
• Levesque J, Antoniadis A, Li PZ, et al. Minimal clinically important difference of 3-minute chair rise test and the DIRECT questionnaire after pulmonary rehabilitation in COPD patients. Int J Chron Obstruct Pulmon Dis. 2019;14:261–269. doi:10.2147/COPD.S187567
   PubMed Web of Science ®Google Scholar
• Watkins ML, Wilcox TK, Tabberer M, et al. Shortness of breath with daily activities questionnaire: validation and responder thresholds in patients with chronic obstructive pulmonary disease. BMJ Open. 2013;3(10):e003048. doi:10.1136/bmjopen-2013-003048
   PubMed Web of Science ®Google Scholar
• Howard K, Berry P, Petrillo J, et al. Development of the shortness of breath with daily activities questionnaire (SOBDA). Value Health. 2012;15(8):1042–1050. doi:10.1016/j.jval.2012.06.018
   PubMed Web of Science ®Google Scholar
• Eakin EG, Resnikoff PM, Prewitt LM, Ries AL, Kaplan RM. Validation of a new dyspnea measure: the UCSD shortness of breath questionnaire. University of California, San Diego. Chest. 1998;113(3):619–624. doi:10.1378/chest.113.3.619
   PubMed Web of Science ®Google Scholar
• Wilcox TK, Chen W-H, Howard KA, et al. Item selection, reliability and validity of the shortness of breath with daily activities (SOBDA) questionnaire: a new outcome measure for evaluating dyspnea in chronic obstructive pulmonary disease. Health Qual Life Outcomes. 2013;11(1):196. doi:10.1186/1477-7525-11-196
   PubMedGoogle Scholar
• Horita N, Miyazawa N, Morita S, et al. Small, moderate, and large changes, and the minimum clinically important difference in the University of California, San Diego shortness of breath questionnaire. COPD. 2014;11(1):26–32. doi:10.3109/15412555.2013.808615
   PubMedGoogle Scholar
• Borg G. Psychophysical bases of perceived exertion. J Med Sci Sports Exerc. 1982;14(5):377–381.
   PubMed Web of Science ®Google Scholar
• Borg G A category scale with ratio properties for intermodal and interindividual comparisons. In: Geissler HG, Petzol P, editors. Psychophysical Judgement and the Process of Perception. Proceedings of the 22nd International Congress of Psychology. Amsterdam, The Netherlands: North Holland Publishing Co; 1980:25–34.
   Google Scholar
• Johnson MJ, Close L, Gillon SC, Molassiotis A, Lee PH, Farquhar MC. Use of the modified Borg scale and numerical rating scale to measure chronic breathlessness: a pooled data analysis. Eur Respir J. 2016;47(6):1861–1864. doi:10.1183/13993003.02089-2015
   PubMed Web of Science ®Google Scholar
• Burdon JG, Juniper EF, Killian KJ, Hargreave FE, Campbell EJ. The perception of breathlessness in asthma. Am Rev Respir Dis. 1982;126(5):825–828. doi:10.1164/arrd.1982.126.5.825
   PubMed Web of Science ®Google Scholar
• Kendrick KR, Baxi SC, Smith RM. Usefulness of the modified 0–10 Borg scale in assessing the degree of dyspnea in patients with COPD and asthma. J Emerg Nurs. 2000;26(3):216–222. doi:10.1016/S0099-1767(00)90093-X
   PubMedGoogle Scholar
• Wilcock A, Crosby V, Clarke D, Tattersfield A. Repeatability of breathlessness measurements in cancer patients. Thorax. 1999;54(4):374. doi:10.1136/thx.54.4.374b
   PubMed Web of Science ®Google Scholar
• Gift AG, Narsavage G. Validity of the numeric rating scale as a measure of dyspnea. Am J Crit Care. 1998;7(3):200–204. doi:10.4037/ajcc1998.7.3.200
   PubMedGoogle Scholar
• Wysham NG, Miriovsky BJ, Currow DC, et al. Practical dyspnea assessment: relationship between the 0–10 numerical rating scale and the four-level categorical verbal descriptor scale of dyspnea intensity. J Pain Symptom Manage. 2015;50(4):480–487. doi:10.1016/j.jpainsymman.2015.04.015
   PubMed Web of Science ®Google Scholar
• Ekström M, Johnson MJ, Huang C, Currow DC. Minimal clinically important differences in average, best, worst and current intensity and unpleasantness of chronic breathlessness. Eur Respir J. 2020;56(2):1902202. doi:10.1183/13993003.02202-2019
   PubMed Web of Science ®Google Scholar
• Johnson MJ, Bland JM, Oxberry SG, Abernethy AP, Currow DC. Clinically important differences in the intensity of chronic refractory breathlessness. J Pain Symptom Manage. 2013;46(6):957–963. doi:10.1016/j.jpainsymman.2013.01.011
   PubMed Web of Science ®Google Scholar
• Banzett RB, O’Donnell CR, Guilfoyle TE, et al. Multidimensional dyspnea profile: an instrument for clinical and laboratory research. Eur Respir J. 2015;45(6):1681–1691. doi:10.1183/09031936.00038914
   PubMed Web of Science ®Google Scholar
• Yorke J, Moosavi SH, Shuldham C, Jones PW. Quantification of dyspnoea using descriptors: development and initial testing of the dyspnoea-12. Thorax. 2010;65(1):21–26. doi:10.1136/thx.2009.118521
   PubMed Web of Science ®Google Scholar
• Ekström MP, Bornefalk H, Sköld CM, et al. Minimal clinically important differences and feasibility of dyspnea-12 and the multidimensional dyspnea profile in cardiorespiratory disease. J Pain Symptom Manage. 2020;60(5):968–975. doi:10.1016/j.jpainsymman.2020.05.028
   PubMed Web of Science ®Google Scholar
• Ekström M, Bornefalk H, Sköld M, et al. Validation of the Swedish multidimensional dyspnea profile (MDP) in outpatients with cardiorespiratory disease. BMJ Open Respir Res. 2019;6(1):e000381. doi:10.1136/bmjresp-2018-000381
   PubMed Web of Science ®Google Scholar
• Tan J-Y, Yorke J, Harle A, et al. Assessment of breathlessness in lung cancer: psychometric properties of the dyspnea-12 questionnaire. J Pain Symptom Manage. 2017;53(2):208–215. doi:10.1016/j.jpainsymman.2016.08.009
   PubMed Web of Science ®Google Scholar
• Yorke J, Swigris J, Russell AM, et al. Dyspnea-12 is a valid and reliable measure of breathlessness in patients with interstitial lung disease. Chest. 2011;139(1):159–164. doi:10.1378/chest.10-0693
   PubMed Web of Science ®Google Scholar
• Williams MT, John D, Frith P. Comparison of the dyspnoea-12 and multidimensional dyspnoea profile in people with COPD. Eur Respir J. 2017;49(3):1600773. doi:10.1183/13993003.00773-2016
   PubMed Web of Science ®Google Scholar
• Yorke J, Armstrong I. The assessment of breathlessness in pulmonary arterial hypertension: reliability and validity of the dyspnoea-12. Eur J Cardiovasc Nurs. 2014;13(6):506–514. doi:10.1177/1474515113514891
   PubMed Web of Science ®Google Scholar
• Meek PM, Banzett R, Parshall MB, Gracely RH, Schwartzstein RM, Lansing R. Reliability and validity of the multidimensional dyspnea profile. Chest. 2012;141(6):1546–1553. doi:10.1378/chest.11-1087
   PubMed Web of Science ®Google Scholar
• Morelot-Panzini C, Gilet H, Aguilaniu B, et al. Real-life assessment of the multidimensional nature of dyspnoea in COPD outpatients. Eur Respir J. 2016;47(6):1668–1679. doi:10.1183/13993003.01998-2015
   PubMed Web of Science ®Google Scholar
• Hegendörfer E, Doukhopelnikoff A, Degryse J-M. Validity and reliability of the multidimensional dyspnoea profile in older adults. ERJ Open Res. 2020:00606–02020.
   Google Scholar
• Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648–654. doi:10.1183/09031936.00102509
   PubMed Web of Science ®Google Scholar
• Leidy NK, Sexton CC, Jones PW, et al. Measuring respiratory symptoms in clinical trials of COPD: reliability and validity of a daily diary. Thorax. 2014;69(5):443–449. doi:10.1136/thoraxjnl-2013-204428
   PubMed Web of Science ®Google Scholar
• Raghavan N, Lam YM, Webb KA, et al. Components of the COPD assessment test (CAT) associated with a diagnosis of COPD in a random population sample. COPD. 2012;9(2):175–183. doi:10.3109/15412555.2011.650802
   PubMedGoogle Scholar
• Marietta von Siemens S, Alter P, Lutter JI, et al. CAT score single item analysis in patients with COPD: results from COSYCONET. Respir Med. 2019;159:105810. doi:10.1016/j.rmed.2019.105810
   PubMed Web of Science ®Google Scholar
• Leidy NK, Murray LT, Monz BU, et al. Measuring respiratory symptoms of COPD: performance of the EXACT- Respiratory Symptoms Tool (E-RS) in three clinical trials. Respir Res. 2014;15(1):124. doi:10.1186/s12931-014-0124-z
   PubMed Web of Science ®Google Scholar
• Nelsen LM, Lee LA, Wu W, et al. Reliability, validity and responsiveness of E-RS:COPD in patients with spirometric asthma-COPD overlap. Respir Res. 2019;20(1):107. doi:10.1186/s12931-019-1070-6
   PubMedGoogle Scholar
• Jones PW, Harding G, Wiklund I, et al. Tests of the responsiveness of the COPD assessment test following acute exacerbation and pulmonary rehabilitation. Chest. 2012;142(1):134–140. doi:10.1378/chest.11-0309
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Garcia-Sidro P, Fernandez-Nistal A, Buendia MJ, Espinosa de Los Monteros MJ, Molina J. Course of COPD assessment test (CAT) and clinical COPD questionnaire (CCQ) scores during recovery from exacerbations of chronic obstructive pulmonary disease. Health Qual Life Outcomes. 2013;11:147. doi:10.1186/1477-7525-11-147
   PubMed Web of Science ®Google Scholar
• Dodd JW, Hogg L, Nolan J, et al. The COPD assessment test (CAT): response to pulmonary rehabilitation. A multicentre, prospective study. Thorax. 2011;66(5):425–429. doi:10.1136/thx.2010.156372
   PubMed Web of Science ®Google Scholar
• Dodd JW, Marns PL, Clark AL, et al. The COPD assessment test (CAT): short- and medium-term response to pulmonary rehabilitation. COPD. 2012;9(4):390–394. doi:10.3109/15412555.2012.671869
   PubMedGoogle Scholar
• Houben-Wilke S, Janssen DJA, Franssen FME, Vanfleteren L, Wouters EFM, Spruit MA. Contribution of individual COPD assessment test (CAT) items to CAT total score and effects of pulmonary rehabilitation on CAT scores. Health Qual Life Outcomes. 2018;16(1):205. doi:10.1186/s12955-018-1034-4
   PubMedGoogle Scholar
• Kon SS, Canavan JL, Jones SE, et al. Minimum clinically important difference for the COPD assessment test: a prospective analysis. Lancet Respir Med. 2014;2(3):195–203. doi:10.1016/S2213-2600(14)70001-3
   PubMed Web of Science ®Google Scholar
• Sandberg J, Ekström M. Differences between experienced and recalled breathlessness: a review. Curr Opin Support Palliat Care. 2019;13(3):161–166. doi:10.1097/SPC.0000000000000448
   PubMed Web of Science ®Google Scholar
• Meek PM, Lareau SC, Anderson D. Memory for symptoms in COPD patients: how accurate are their reports? Eur Respir J. 2001;18(3):474–481. doi:10.1183/09031936.01.00083501
   PubMed Web of Science ®Google Scholar
• Elmberg V, Ekstrom M. Effect of the trajectory of exertional breathlessness on symptom recall and anticipation: a randomized controlled trial. PLoS One. 2020;15(9):e0238937. doi:10.1371/journal.pone.0238937
   PubMed Web of Science ®Google Scholar
• Ekström M, Elmberg V, Lindow T, Wollmer P. Breathlessness measurement should be standardised for the level of exertion. Eur Respir J. 2018;51(5):1800486. doi:10.1183/13993003.00486-2018
   PubMedGoogle Scholar
• Lewthwaite H, Koch EM, Tracey L, Jensen D. Standardized measurement of breathlessness during exercise. Curr Opin Support Palliat Care. 2019;13(3):152–160. doi:10.1097/SPC.0000000000000443
   PubMed Web of Science ®Google Scholar
• Ekström M. Why treatment efficacy on breathlessness in laboratory but not daily life trials? The importance of standardized exertion. Curr Opin Support Palliat Care. 2019;13(3):179–183. doi:10.1097/SPC.0000000000000444
   PubMed Web of Science ®Google Scholar
• Ries AL. Minimally clinically important difference for the UCSD shortness of breath questionnaire, Borg Scale, and Visual Analog Scale. COPD. 2005;2(1):105–110. doi:10.1081/COPD-200050655
   PubMedGoogle Scholar
• Cazzola M, MacNee W, Martinez FJ, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J. 2008;31(2):416–469. doi:10.1183/09031936.00099306
   PubMed Web of Science ®Google Scholar
• Jones PW, Beeh KM, Chapman KR, Decramer M, Mahler DA, Wedzicha JA. Minimal clinically important differences in pharmacological trials. Am J Respir Crit Care Med. 2014;189(3):250–255. doi:10.1164/rccm.201310-1863PP
   PubMed Web of Science ®Google Scholar
• Palange P, Ward S, Carlsen K, et al. Recommendations on the use of exercise testing in clinical practice. Eur Respir J. 2007;29(1):185–209. doi:10.1183/09031936.00046906
   PubMed Web of Science ®Google Scholar
• Perrault H, Baril J, Henophy S, Rycroft A, Bourbeau J, Maltais F. Paced-walk and step tests to assess exertional dyspnea in COPD. COPD. 2009;6(5):330–339. doi:10.1080/15412550903156317
   PubMedGoogle Scholar
• O’Donnell DE, Maltais F, Porszasz J, et al. The continuum of physiological impairment during treadmill walking in patients with mild-to-moderate COPD: patient characterization phase of a randomized clinical trial. PLoS One. 2014;9(5):e96574. doi:10.1371/journal.pone.0096574
   PubMed Web of Science ®Google Scholar
• Lewthwaite H, Li PZ, O’Donnell DE, Jensen D. Multidimensional breathlessness response to exercise: impact of COPD and healthy ageing. Respir Physiol Neurobiol. 2021;287:103619. doi:10.1016/j.resp.2021.103619
   PubMed Web of Science ®Google Scholar
• Faisal A, Alghamdi BJ, Ciavaglia CE, et al. Common mechanisms of dyspnea in chronic interstitial and obstructive lung disorders. Am J Respir Crit Care Med. 2016;193(3):299–309. doi:10.1164/rccm.201504-0841OC
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Guenette JA, Maltais F, Webb KA. Decline of resting inspiratory capacity in COPD: the impact on breathing pattern, dyspnea, and ventilatory capacity during exercise. Chest. 2012;141(3):753–762. doi:10.1378/chest.11-0787
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Travers J, Webb KA, et al. Reliability of ventilatory parameters during cycle ergometry in multicentre trials in COPD. Eur Respir J. 2009;34(4):866–874. doi:10.1183/09031936.00168708
   PubMed Web of Science ®Google Scholar
• Mador MJ, Rodis A, Magalang UJ. Reproducibility of Borg scale measurements of dyspnea during exercise in patients with COPD. Chest. 1995;107(6):1590–1597. doi:10.1378/chest.107.6.1590
   PubMed Web of Science ®Google Scholar
• Peters MM, Webb KA, O’Donnell DE. Combined physiological effects of bronchodilators and hyperoxia on exertional dyspnoea in normoxic COPD. Thorax. 2006;61(7):559–567. doi:10.1136/thx.2005.053470
   PubMed Web of Science ®Google Scholar
• Eves ND, Sandmeyer LC, Wong EY, et al. Helium-hyperoxia: a novel intervention to improve the benefits of pulmonary rehabilitation for patients with COPD. Chest. 2009;135(3):609–618. doi:10.1378/chest.08-1517
   PubMed Web of Science ®Google Scholar
• Abdallah SJ, Wilkinson-Maitland C, Saad N, et al. Effect of morphine on breathlessness and exercise endurance in advanced COPD: a randomised crossover trial. Eur Respir J. 2017;50(4):1701235. doi:10.1183/13993003.01235-2017
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Fluge T, Gerken F, et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J. 2004;23(6):832–840. doi:10.1183/09031936.04.00116004
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Voduc N, Fitzpatrick M, Webb KA. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J. 2004;24(1):86–94. doi:10.1183/09031936.04.00072703
   PubMed Web of Science ®Google Scholar
• Maltais F, Hamilton A, Marciniuk D, et al. Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Chest. 2005;128(3):1168–1178. doi:10.1378/chest.128.3.1168
   PubMed Web of Science ®Google Scholar
• Zhang J, Schaeffer MR, Mitchell RA, et al. A multidimensional assessment of dyspnoea in healthy adults during exercise. Eur J Appl Physiol. 2020;120(11):2533–2545. doi:10.1007/s00421-020-04479-2
   PubMed Web of Science ®Google Scholar
• Lewthwaite H, Jensen D. Multidimensional breathlessness assessment during cardiopulmonary exercise testing in healthy adults. Eur J Appl Physiol. 2021;121(2):499–511. doi:10.1007/s00421-020-04537-9
   PubMed Web of Science ®Google Scholar
• Neder JA, Berton DC, Nery LE, et al. A frame of reference for assessing the intensity of exertional dyspnoea during incremental cycle ergometry. Eur Respir J. 2020;56(4):2000191. doi:10.1183/13993003.00191-2020
   PubMed Web of Science ®Google Scholar
• Tsiligianni I, Kocks JWH. Daytime symptoms of chronic obstructive pulmonary disease: a systematic review. NPJ Prim Care Respir Med. 2020;30(1):6. doi:10.1038/s41533-020-0163-5
   PubMed Web of Science ®Google Scholar
• Williams MT, Johnston KN. Multidimensional measurement of breathlessness: recent advances. Curr Opin Support Palliat Care. 2019;13(3):184–192. doi:10.1097/SPC.0000000000000436
   PubMed Web of Science ®Google Scholar
• Mahler DA, Sethi S. Enhanced drug and device development by targeting “Relief of Dyspnea”. Chest. 2020;158(2):464–466. doi:10.1016/j.chest.2020.04.040
   PubMed Web of Science ®Google Scholar